Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 1, January, p. 39–44

doi: 10.17219/acem/66392

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Computerized planimetry evaluation of hyperbaric oxygen therapy in the treatment of diabetic foot

Marek Kawecki1,2,A,B,D,E, Jarosław Pasek3,4,A,C,D,E, Grzegorz Cieślar3,4,D,E,F, Aleksander Sieroń3,A,B,E,F, Grzegorz Knefel1,C,E,F, Mariusz Nowak4,C,F, Justyna Glik1,C,E,F

1 Centre for Burns Treatment, Siemianowice Śląskie, Poland

2 Department of Health Sciences, Technical-Humanistic Academy, Bielsko-Biała Poland

3 Department of Internal Medicine, Angiology and Physical Medicine, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland

4 Academy of Jan Długosz in Częstochowa, Institute of Physical Education Tourism and Physiotherapy, Częstochowa, Poland

Abstract

Background. Diabetic foot ulcer is one of the major complications of diabetes mellitus in adults.
Objectives. The aim of the study was to conduct a planimetry evaluation of the effectiveness of hyperbaric oxygen therapy (HBOT) in the treatment of patients with vascular disorders caused by diabetic foot.
Material and Methods. The study included 94 patients, 30 females (32%) and 64 males (68%), aged 33–76 years, with diabetes lasting 1.5–32 years, who underwent HBOT due to diabetic foot. All patients from that group underwent vascular procedures prior to HBOT. In qualifying patients for hyperbaric oxygen therapy, transcutaneous oximetry method was applied (30–60 exposures in hyperbaric oxygen at pressure of 2.5 ATA). Progress in wound healing was evaluated by computerized planimetry system IRIS 4.
Results. In 26 patients the wounds were completely closed and in 37 patients the topical state was significantly improved – the wound surface decreased by 34% in average. During the treatment, in 11 patients amputation of fingers and metatarsal necrotic bones was performed, while in 9 patients amputation was prevented.
Conclusion. A planimetry evaluation showed that the application of HBOT in the treatment of diabetic foot enhances foot ulcer healing, reduces tissue damage, contributes to the reduction of complications related to soft tissue and bone infections.

Key words

diabetic foot, hyperbaric oxygen therapy, computerized planimetry

References (15)

  1. Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag. 2007;3:65–76.
  2. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117:1219–1222.
  3. Pecoraro RE, Reiber EM, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990;13:513–521.
  4. Rudzki J, Sadliński C, Ginko T, et al. Problem of treating of the so-called diabetic foot. Wiad Lek. 1985;38:417–420.
  5. Armstrong DG, Lavery LA, Harkles LB. Validation of a diabetic wound classification system: The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998;21:855–859.
  6. Gottlieb SF. Oxygen under pressure and microorganisms, In: Davis JC, Hunt TK, eds. Hyperbaric oxygen therapy. Bethesda: Undersea Medical Society Inc.; 1986:79–99.
  7. Hamilton Farrell MR. Fourth Consensus Conference of the European Committee on Hyperbaric Medicine, London. December 4–5 1998. Hyperbaric oxygen in the management of foot lesions in diabetic patients. Diabetes Nutr Metab. 1999;12:47–48.
  8. Wattel F, Mathieu D. Methodology for assessing hyperbaric oxygen therapy in clinical practice. In: Mathieu D, ed. Handbook on hyperbaric medicine. Dodrecht: Springer; 2006:163–170.
  9. Abidia A, Laden G, Kuhan G, et al. The role of hyperbaric oxygen therapy in ischemic diabetic lower extremity ulcers: A double-blind randomized-controlled trial. Eur J Vasc Endovasc Surg. 2003;25:513–518.
  10. Duzgun AP, Satir HZ, Ozozan O, Saylam B, Kulah B, Coskun F. Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. J Foot Ankle Surg. 2008;47:515–519.
  11. Kalani M, Jörneskog G, Naderi N, Lind F, Brismar K. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers: Long-term follow-up. J Diabetes Complications. 2002;16:153–158.
  12. Löndahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33:998–1003.
  13. Kessler L, Bilbault P, Ortéga F, et al. Hyperbaric oxygenation accelerates the healing rate of non- ischemic chronic diabetic foot ulcers: A prospective randomized study. Diabetes Care. 2003;26:2378–2382.
  14. Mayrovitz HN, Soontupe LB. Wound areas by computerized planimetry of digital images: Accuracy and reliability. Adv Skin Wound Care. 2009;22:222–229.
  15. Cianci P, Hunt TK. Long term results of aggressive management of diabetic foot ulcers suggest significant cost effectiveness. Wound Repair Regen. 1997;5:141–146.
© Wroclaw Medical University